PAINWeek, the largest US pain conference for Frontline Practitioners, announced that the 2014 Conference will feature a new course track exploring the current prescribing environment for medical marijuana in the treatment of chronic pain from both medical and legal perspectives.
This new track, to be presented on Saturday, September 6, will include consideration of best medical practice with medical marijuana, appropriate point of care testing, distinguishing appropriate vs inappropriate use, the medical marijuana ecosystem and legal perspective, and perspective on the evolving status of cannabis for medical and recreational use.
Veteran PAINWeek faculty member, Michael Schatman, commented on the announcement: “The empirical support for certain cannabinoids in the treatment of pain is increasing rapidly [but] the regulatory landscape across levels of government continues to be complex. Consequently, we continue to observe reluctance by clinicians to authorize their use. My colleagues and I hope to provide our attendees with new empirical data and perspectives that will help them to appropriately incorporate medical cannabis into their treatment arsenals.”
In total, the PAINWeek curriculum now encompasses over 120 CE/CME course hours, enabling attendees to earn 39 AMA PRA Category 1 Credits. Significant registration discounts are available to individuals and groups during “early-bird” registration until July 31, 2014.
To learn more and register for PAINWeek 2014, visit: http://www.painweek.org.
